12/20/2024
8:16 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024
6:22 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
6:31 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
6:54 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
7:50 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024
6:32 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
7:09 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/16/2024
6:27 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
6:39 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024
8:22 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024
8:46 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
7:20 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 424B5 | |
08/26/2024
5:18 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
4:18 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K/A | |
08/15/2024
7:15 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
6:07 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
5:13 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
5:15 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K/A | |
08/12/2024
5:03 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
6:30 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
8:04 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/08/2024
4:16 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/08/2024
2:20 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024
6:49 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
6:34 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2024
6:31 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
7:28 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
6:30 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
7:15 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
3:51 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
7:01 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
5:02 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
7:31 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
7:33 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
6:49 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
7:01 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024
7:01 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
7:03 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
3:57 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2024
8:22 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/27/2024
7:01 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
DeFi Coin on Verge of Breakout! (Ad) The blueprint for millionaires is here.
Don't let this be the missed opportunity you regret for years.
 Claim your FREE book now before it's too late! |
03/11/2024
7:00 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024
7:02 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
7:00 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024
7:04 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:01 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:05 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024
2:56 PM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2024
6:38 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
